The Australian breast cancer charity has provided $ 10 million for treatment research and early detection in an effort to meet the ambitious target of zero breast cancer deaths by 2030.
The National Breast Cancer Foundation has selected 16 research projects to be funded from among one hundred potential applicants for its annual grant program.
Eight women die and 53 are diagnosed with breast cancer in Australia every day.
And although the survival rate has increased, increasing from only 76 percent in 1994 to 91 percent, the number of new cases has also increased.
Without research, every step of Lindy Lifszyc’s fight against cancer would be very different.
“The research led me to have multiple mastectomies and simultaneous reconstructive surgeries in one operation,” said Ms. Lifszyc.
While scalp cooling technology allows Melbourne’s three-member mother to maintain enough hair for thin ponytails.
“It sounds trivial but it stops me from looking like a cancer patient. I can pick up my children from school and do shopping – normal things – while undergoing chemo,” said the mother of three children.
Now 44 years old, he was diagnosed with early stage breast cancer just before Christmas in 2015 after seeing a thick area in his right breast.
Despite having a mammogram six months earlier, the general practitioner scheduled an ultrasound that showed two suspicious lumps.
The surgeon will proceed to remove 12 tumors that stretch a total of six centimeters.
Ms. Lifszyc encourages women to listen to their bodies and take advantage of the various tests available.
“I try to convey the importance of ultrasound, especially for women with dense breast tissue. Mammograms do not show cancer but can be seen on ultrasonography or MRI,” he said.
After the last session of radiation therapy, he held a cocktail party at his home in Melbourne, raising $ 23,000 for NBCF.
The charity’s chief executive said community contributions were crucial to the foundation’s financial health, especially during COVID-19, which had made fundraising “very challenging”.
“We have to rediscover the way we do things. Without events, we are fortunate that different corporate partnerships and large donors have increased,” he said.
Research has also been closed with laboratories due to social distance and lack of university funding after the exodus of international students.
However, Professor Hoskings said the NBCF grant recipient was working on some interesting developments using new technology, including artificial intelligence and immunotherapy.
University of Queensland researcher Robert Mazzieri is testing a new vaccine to improve the body’s own immune response to breast cancer when combined with other immunotherapy.
“This is for triple-negative breast cancer and brain metastases which tend to have poor results,” Professor Hoskings said.
He is also interested in research on JNK protein, both of which spread cancer and protect it from healthy breast tissue.
David Croucher, from the Garvan Institute of Medical Research in NSW, believes the “protein scaffold” that controls JNK activity can be targeted by drugs and inhibits the growth of cancer cells.
Professor Hoskings said the aim of his organization to end death from breast cancer by 2030 was brave but doable.
“More than 44,000 additional lives are saved each year compared to when we started in 1994,” he said.
“Through the generosity of the community we can continue to fund these projects which then save lives,” he said.
to request modification Contact us at Here or [email protected]